Literature DB >> 27338547

Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.

Mu-Xing Li1, Xin-Yu Bi1, Zhi-Yu Li1, Zhen Huang1, Yue Han2, Jian-Jun Zhao1, Hong Zhao3, Jian-Qiang Cai4.   

Abstract

BACKGROUND: Conflicting results about the prognostic value of surgical margin status in patients with intrahepatic cholangiocarcinoma (ICC) have been reported. We aimed to assess the association between surgical margin status and prognosis in ICC through a meta-analysis.
MATERIALS AND METHODS: We conducted a literature search of the articles evaluating the prognostic value of surgical margin status in patients with ICC. The pooled estimation of the hazard ratio (HR) with the 95% confidence interval (CI) was performed to determine the influence of surgical margin status on the survival outcome.
RESULTS: A total of 21 studies involving 3201 patients were finally included into the meta-analysis. The percentage of patients with positive surgical margin ranged from 7.2% to 75.9% in the enrolled studies. The pooled estimates showed that patients with positive surgical margin had inferior overall survival (HR: 1.864; 95% CI: 1.542-2.252; P < 0.001) and progression-free survival (HR: 2.033; 95% CI: 1.030-4.011; P = 0.041) than patients with negative ones. The subgroup analyses and sensitivity analyses were consistent with the overall results.
CONCLUSIONS: Patients with negative surgical margin had significantly favorable overall survival and progression-free survival after surgical resection for ICC. The notion of achieving the R0 resection should be emphasized.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intrahepatic cholangiocarcinoma; Meta-analysis; Prognosis; Surgical margin

Mesh:

Year:  2016        PMID: 27338547     DOI: 10.1016/j.jss.2016.02.012

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  14 in total

1.  Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.

Authors:  Jian Feng; Bin Liang; Hang-Yu Zhang; Zhe Liu; Kai Jiang; Xiang-Qian Zhao
Journal:  World J Gastrointest Surg       Date:  2022-05-27

2.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

3.  The Landmark Series: Intrahepatic Cholangiocarcinoma.

Authors:  Jordan M Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2020-05-17       Impact factor: 5.344

4.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

5.  Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma.

Authors:  Chenyue Zhang; Haiyong Wang; Zhouyu Ning; Litao Xu; Liping Zhuang; Peng Wang; Zhiqiang Meng
Journal:  Onco Targets Ther       Date:  2017-03-06       Impact factor: 4.147

6.  Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels.

Authors:  Xuan Zheng; Bo Chen; Jian-Xiong Wu; Angela Y Jia; Wei-Qi Rong; Li-Ming Wang; Fan Wu; Yu-Ting Zhao; Ye-Xiong Li; Wei-Hu Wang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

7.  Nonanatomic resection is not inferior to anatomic resection for primary intrahepatic cholangiocarcinoma: A propensity score analysis.

Authors:  B Li; J L Song; Y Aierken; Y Chen; J L Zheng; J Y Yang
Journal:  Sci Rep       Date:  2018-12-12       Impact factor: 4.379

8.  Precision surgery for primary liver cancer.

Authors:  Takeshi Takamoto; Masatoshi Makuuchi
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

Review 9.  Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis.

Authors:  Qiao Ke; Bin Wang; Nanping Lin; Lei Wang; Jingfeng Liu
Journal:  World J Surg Oncol       Date:  2019-12-09       Impact factor: 2.754

10.  Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study.

Authors:  Hongzhi Liu; Lianku Lin; Ziguo Lin; Yifan Chen; Qizhen Huang; Lei Ding; Jianying Lou; Shuguo Zheng; Xinyu Bi; Jianming Wang; Wei Guo; Fuyu Li; Jian Wang; Yamin Zheng; Jingdong Li; Shi Cheng; Weiping Zhou; Zhangjun Cheng; Yongyi Zeng
Journal:  BMC Cancer       Date:  2021-07-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.